The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

To help address the impact of COPD on patients and communities, global healthcare companies Sanofi and Regeneron are working together to study the ripple effects of COPD and to help create a ...

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

Sanofi plans to boost its U.S.-based research and development and manufacturing investments to at least $20 billon over the next five years. In a May 14 press release, the French multinational ...

We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the bulls’ thesis on SNY. Sanofi (SNY)’s share was trading at $51.06 ...

Hawaii had alleged the companies violated state consumer protection laws by marketing Plavix without disclosing that the drug could have a diminished or no effect for some people, particularly of ...

The NAPFA score integrates clinical features to streamline pediatric food allergy diagnosis, potentially reducing delays and costs. Food allergies affect 8% of children under 5, with diagnostic ...

PORTLAND, Ore. (KATU) — The Portland Pickles baseball team has filed a lawsuit against Disney for trademark infringement, claiming a team logo featured in a new Pixar TV series is hitting too ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s last program in the process. IGM responded by laying off 80% of its staff and closing most of its lab and ...

Design agency Koto has collaborated with online retailer Amazon's design team Amazon XCM in a rebrand of the company's distinct smile logo, while simplifying the identity of over 50 Amazon sub-brands.

HONOLULU, Hawaii (Island News) -- Hawaii will receive $700 million in a landmark drug settlement against pharmaceutical bigwigs Bristol Myers Squibb and Sanofi. The settlement, the largest in ...

Sanofi has turned its back on its partner IGM Biosciences, forcing the small California biotech to enact drastic strategic measures, including an 80% reduction in force. IGM made the announcement in ...